ReviewMolecular cancer2022
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.
Yuze Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
294 papers cite itlatest 60 shown
this paperpooled itcites it